Santen Enters into Collaboration and Distribution Agreement with Glaukos

Santen Pharmaceutical Co., Ltd.

Represented Santen Pharmaceutical Co., Ltd. in connection with a multi-year Collaboration and Distribution Agreement between the company's U.S. subsidiary, Santen, Inc., and Glaukos Corporation (NYSE: GKOS), pursuant to which Glaukos will become the exclusive distributor of the MicroShunt solely in the U.S. market. Read the press release.

Santen is a leading ophthalmic company that focuses on the research, development, marketing and sales of pharmaceuticals. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and currently sells its products in over 60 countries. Glaukos is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.